XprESS Maxillary Balloon Dilation Study

NCT01525862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2020-11-10

Study results available
· View outcomes & findings →

Summary

A prospective, single-arm, post approval pilot study.

Conditions

  • Chronic Sinusitis
  • Chronic Rhinosinusitis (Diagnosis)

Interventions

DEVICE

Balloon sinus dilation

Sponsors & Collaborators

  • Entellus Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • James D. Gould, MD · Synergy ENT Specialists

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-01-31
Completion
2013-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01525862 on ClinicalTrials.gov